Atlas Trials

Liposome-Encapsulated Doxorubicin Citrate With or Without Gemcitabine Hydrochloride in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer

Clinical trial NCT01100372 · UNKNOWN

Trial details

NCT number
NCT01100372
Sponsor
Medical University Innsbruck
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer
Start date
2009-07-01
Primary completion
2014-05-01
Enrollment
154

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.